Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
What were the critical steps in the development of ATRA and arsenic as treatments for APL? Researchers in Shanghai tell the story and look to the future
Main Authors: | Zhou, Guang-Biao, Zhao, Wei-Li, Wang, Zhen-Yi, Chen, Sai-Juan, Chen, Zhu |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2005
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545204/ |
Similar Items
-
Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide
by: Shen, Yang, et al.
Published: (2015) -
Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial
by: Li Zhang, et al.
Published: (2018-04-01) -
Retinoic Acid and Arsenic Synergize to Eradicate Leukemic Cells in a Mouse Model of Acute Promyelocytic Leukemia
by: Lallemand-Breitenbach, Valérie, et al.
Published: (1999) -
Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-trans retinoic acid and arsenic compound-based combined therapies
by: LU, JIN, et al.
Published: (2014) -
Significance of ETV6 rearrangement in acute promyelocytic leukemia with t(15;17)/promyelocytic leukemia/retinoic acid receptor alpha
by: GAO, NA, et al.
Published: (2016)